That was what I was referring to (-;
http://www.the-scientist.com/?articles.view/articleNo/43804/title/Inner-Ear-Cartography/
When I read the following in this article: "Within the mammalian cochlea, apical cells retain regenerative capacity for a few weeks after birth, but basal cells do not."
This was in 2015. By now researchers should have the information what the difference is between these cells?
Most inner ear hearing loss is in this area.
What makes it such a challenge?
Yes, the "Inner Ear Cartography" by Heller et. al. has been published in 2015. I think that was a major breakthrough. Simply put, many of the general types of cells such as outer hair cells display genetic differences along the sensory epithelium.
One of the findings in that same study was that "apical cells retain regenerative capacity for a few weeks after birth, but basal cells do not". Apical cells are closer to the apex of the cochlea and correspond to low frequencies. Basal cells are closer to the base or the entrance to the cochlea and correspond to high frequencies. So what's the difference? Why do for example outer hair cells at the apex display regenerative properties, while the outer hair cells at the base do not? Also, what causes the basal cells to loose their regenerative properties?
Most of the hearing loss happens at the high frequencies. This is thought to be because of their close proximity to the sound source. But the genetic properties might also play an important role in the death or survival of high frequency cells. This brings on the question of whether or not genetic predisposition makes some people more tolerable to high frequency hearing loss?
These are all great questions! But I can't answer them yet. We know a lot more about these cells. But we still don't have a full picture. Helge Rask Andersen worked on mapping the nerve cells in the cochlea, and he also discovered that there are genetic and functional differences between them, depending on what frequency they signal to the brain. So they are not just a bunch of nerve cells here and there. Each one is unique and has an important role to play.
These are important realizations! Even if we don't fully understand it just yet. To quote Socrates, "True knowledge exists in knowing that you know nothing."
We need to dive deeper and learn more. Decibel Tx seems to be expanding on this previous work.
On the Otostem project website, they state:
The lack of human otic cell models represents a significant roadblock hampering the development of drug-based or cell-based therapies.
The word "otic" refers to the ear. In other words they need to know more about the cells of the inner ear. Their genetic profiles, function, and location within the cochlea. So that they can create a precise model which they can use to create successful therapies. So this part relates to not knowing what is what inside the cochlea. Well, it's not that they don't know, it's that they want to and need to know more to get better results.
This is why they need to find new genetic markers that will help them identify and locate cell types when doing RNA sequencing. They don't have that for all the cell types, which the recent Decibel publication indicates. (They identified many thanks to previous knowledge, but they also had some leftovers they couldn't tell anything about.)
Then you have the problem of targeting specific cells at specific locations. This relates and depends on the cellular models and knowing what is what and where it's at. Next to the first part, I think this will be the hardest.
Then you have the delivery method. You can't easily access the cochlea to deliver the treatment. The only natural way to access the cochlea is through the nose, through the Eustachian tube. But previous attempts to access the cochlea this way for diagnostic purposes proved close to impossible. This was done a couple of years ago. The probe needs to be about 1 mm thick which is a very tiny probe. You need to equip it with jet sprays to clear the way and a light source, and a video lens. This was technically not possible back then, and I don't think it is possible with current technology either. Maybe there will be some innovation that will allow for this in the future, maybe some nano scale lenses and light diodes. But currently, the best way to access the cochlea is through the tympanic membrane.
Whenever you want to access the cochlea with an instrument, you will most likely enter through the tympanic membrane. Then you enter the oval window and deliver the treatment. In case of gene therapy, viral vectors are released and they enter the cells and deliver a copy of the genes they carry into the nuclei. Once inside the nuclei, a promotor is used to initialize the production of proteins that will go on to build the new cells.
Another problem is the viral vectors. They need to be safe for humans. At the same time, they must be able to survive the delivery of the genes or stem cells. The viral vectors function like protective shells. The organ of Corti is submerged in a fluid called the Endolymph. This fluid is toxic, even to the sensory hair cells that live inside it. The hair cells don't normally have contact with this fluid, only their stereocilia bundles do. The cells are underneath, in the epithelial columns of the organ of Corti. Viral vectors carrying genes or stem cells need to reach the epithelium and deliver the payload before Endolymph gets to them. This is part of the success of one viral vector over another. We need to find just the right kind. There is also the endolymphatic sac which has been shown to have immunologic function. The viral vector should not cause immune response in order to survive and deliver the payload.